Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma

Overview of attention for article published in OncoTargets and therapy, September 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 61 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 429 followers.

Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma http://t.co/3ye60tMr #multiplemyeloma #proteasome @carfilzomib

Reply Repost Favourite